Juniper Biomedical

About Juniper Biomedical

Juniper Biomedical is focused on revolutionizing pelvic health therapy by providing dramatically improved treatment options for patients with conditions such as urinary incontinence, bowel incontinence, pelvic pain, and sexual dysfunction. Their mission is to restore human nature by addressing care gaps with innovative solutions.

Products & Services

Precision Neuromodulation Platform:A less invasive, safer, and more effective therapy option for pelvic health conditions, featuring minimally invasive implantation, low skill requirement for implantation, and precise, selective, low-power therapy.

Specialties

Pelvic Health Therapy Neuromodulation Technology Minimally Invasive Implants

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series Seed T: - FT: Series Seed	A: 3000000 MR: - FA: $3M FAN: 3000000	D: 2024-04-02 FD: 2024-04-02	5 investors

Series Seed Latest

2024-04-02

$3.0M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

David N. Constantine

CO-FOUNDER & CEO

M

Mario Romero-Ortega

CO-FOUNDER & CHIEF SCIENCE OFFICER

G

Gregory Martin, PhD

CHIEF TECHNOLOGY OFFICER

J

Jayme Coates

Chief Operating Officer

J

Jessica DeLong

Chief Medical Officer

R

Robert Swain

CLINICAL & REGULATORY AFFAIRS

View 38 more team members with Pro

Unlock Full Team Directory

Recent News